Liver ultrasound may offer a new window into heart health in the ICU

NCT ID NCT07732114

Recruiting now Diagnosis Sponsor: Menoufia University Source: ClinicalTrials.gov ↗

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This study tests whether a liver ultrasound measurement — the hepatic vein systolic filling fraction — can accurately assess right heart function in critically ill patients on mechanical ventilators. Researchers will compare this new method to the standard TAPSE measurement in 115 ICU adults. If proven reliable, it could provide a simpler, non-invasive way to monitor heart function at the bedside.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hepatic vein systolic filling fraction measurement via Doppler ultrasound
What this could lead to: If accurate, this ultrasound technique could offer a simpler, non-invasive way to monitor heart function in ICU patients on ventilators.
What could go wrong: This is a small, early diagnostic study. The measurement may not prove reliable enough to replace standard methods, and results may not apply to all ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICALLY ILL INTENSIVE CARE UNIT PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICALLY ILL INTENSIVE CARE UNIT PATIENTS

Contacts and locations

Locations

Menoufia University
RECRUITING

Alexandria, Shebin El-Kom, 32511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.